IL-6 and TNF-α induced obesity-related inflammatory response through transcriptional regulation of miR-146b

Journal of Interferon and Cytokine Research

Volumn 34, Issue 5, 2014, Pages 342-348

  Shi, Chunmei ^a,b   Zhu, Lijun ^a   Chen, Xiaohui ^a   Gu, Nan ^a   Chen, Ling ^a   Zhu, Lu ^a   Yang, Lei ^a   Pang, Lingxia ^a   Guo, Xirong ^a   Ji, Chenbo ^a   Zhang, Chunmei ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; INTERLEUKIN 6; LUCIFERASE; MICRORNA; MICRORNA 103; MICRORNA 146B; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; MIRN146 MICRORNA, HUMAN;

ADIPOCYTE; ADIPOSE TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FLUORESCENCE; HEK293 CELL LINE; HUMAN; HUMAN CELL; OBESITY; PRIORITY JOURNAL; PROADIPOCYTE; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; UPREGULATION; CELL CULTURE; GENETICS; IMMUNOLOGY; INFLAMMATION; TRANSCRIPTION INITIATION;

CELLS, CULTURED; HUMANS; INFLAMMATION; INTERLEUKIN-6; MICRORNAS; OBESITY; TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84900337523     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2013.0078     Document Type: Article

References (34)

1. Alexander R, Lodish H, Sun L. 2011. MicroRNAs in adipogenesis and as therapeutic targets for obesity. Expert Opin Ther Targets 15(5):623-636.
2. Ambros V. 2004. The functions of animal microRNAs. Nature 431(7006):350-355.
3. Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281-297.
4. Bastard JP, Maachi M, Van Nhieu JT, Jardel C, Bruckert E, Grimaldi A, Robert JJ, Capeau J, Hainque B. 2002. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 87(5):2084-2089.
5. Bhaumik D, Scott GK, Schokrpur S, Patil CK, Orjalo AV, Rodier F, Lithgow GJ, Campisi J. 2009. MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging (Albany NY), 1(4):402-411.
6. Chartoumpekis DV, Zaravinos A, Ziros PG, Iskrenova RP, Psyrogiannis AI, Kyriazopoulou VE, Habeos IG. 2012. Differential expression of microRNAs in adipose tissue after long-term high-fat diet-induced obesity in mice. PLoS One 7(4):e34872.
7. Despres JP, Lemieux I. 2006. Abdominal obesity and metabolic syndrome. Nature 444(7121):881-887.
8. Dusserre E, Moulin P, Vidal H. 2000. Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues. Biochim Biophys Acta 1500(1):88-96.
9. Fried SK, Bunkin DA, Greenberg AS. 1998. Omental and subcutaneous adipose tissues of obese subjects release interleukin- 6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83(3):847-850.
10. Ge Q, Gerard J, Noel L, Scroyen I, Brichard SM. 2012. Micro- RNAs regulated by adiponectin as novel targets for control- ling adipose tissue inflammation. Endocrinology 153(11): 5285-5296.
11. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. 1996. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesityinduced insulin resistance. Science 271(5249):665-668.
12. Hotamisligil GS, Shargill NS, Spiegelman BM. 1993a. Adipose expression of tumor necrosis factor-alpha: direct role in obesity- linked insulin resistance. Science 259(5091):87-91.
13. Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS, Welch DR. 2009. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res 69(4):1279-1283.
14. Iozzo P. 2009. Viewpoints on the way to the consensus session: where does insulin resistance start? The adipose tissue. Diabetes Care 32 Suppl 2: S168-S173.
15. Kolfschoten IG, Roggli E, Nesca V, Regazzi R. 2009. Role and therapeutic potential of microRNAs in diabetes. Diabetes Obes Metab 11 Suppl 4:118-129.
16. Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, Stumvoll M, Fasshauer M. 2005. Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 289(4):E586-E590.
17. Kutty RK, Nagineni CN, Samuel W, Vijayasarathy C, Jaworski C, Duncan T, Cameron JE, Flemington EK, Hooks JJ, Redmond TM. 2013. Differential regulation of microRNA-146a and microRNA-146b-5p in human retinal pigment epithelial cells by interleukin-1beta, tumor necrosis factor-alpha, and interferon-gamma. Mol Vis 19:737-750.
18. Ling HY, Hu B, Hu XB, Zhong J, Feng SD, Qin L, Liu G, Wen GB, Liao DF. 2012. MiRNA-21 reverses high glucose and high insulin induced insulin resistance in 3T3-L1 adipocytes through targeting phosphatase and tensin homologue. Exp Clin Endocrinol Diabetes 120(9):553-559.
19. Liu S, Yang Y, Wu J. 2011. TNFalpha-induced up-regulation of miR-155 inhibits adipogenesis by down-regulating early adipogenic transcription factors. Biochem Biophys Res Commun 414(3):618-624.
20. McGregor RA, Choi MS. 2011. microRNAs in the regulation of adipogenesis and obesity. Curr Mol Med 11(4):304-316.
21. Navab M, Gharavi N, Watson AD. 2008. Inflammation and metabolic disorders. Curr Opin Clin Nutr Metab Care 11(4): 459-464.
22. Neville MJ, Collins JM, Gloyn AL, McCarthy MI, Karpe F. 2011. Comprehensive human adipose tissue mRNA and microRNA endogenous control selection for quantitative real-time-PCR normalization. Obesity (Silver Spring) 19(4):888-892.
23. Shoelson SE, Herrero L, Naaz A. 2007. Obesity, inflammation, and insulin resistance. Gastroenterology 132(6):2169-2180.
24. Smale ST, Kadonaga JT. 2003. The RNA polymerase II core promoter. Annu Rev Biochem 72:449-479.
25. Sonkoly E, Stahle M, Pivarcsi A. 2008. MicroRNAs: novel regulators in skin inflammation. Clin Exp Dermatol 33(3):312-315.
26. Stanczyk J, Pedrioli DM, Brentano F, Sanchez-Pernaute O, Kolling C, Gay RE, Detmar M, Gay S, Kyburz D. 2008. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum 58(4):1001-1009.
27. Taganov KD, Boldin MP, Chang KJ, Baltimore D. 2006. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 103(33):12481-12486.
28. Trayhurn P, Wood IS. 2004. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92(3):347-355.
29. Weis L, Reinberg D. 1992. Transcription by RNA polymerase II: initiator-directed formation of transcription-competent complexes. FASEB J 6(14):3300-3309.
30. Wellen KE, Fucho R, Gregor MF, Furuhashi M, Morgan C, Lindstad T, Vaillancourt E, Gorgun CZ, Saatcioglu F, Hotamisligil GS. 2007. Coordinated regulation of nutrient and inflammatory responses by STAMP2 is essential for metabolic homeostasis. Cell 129(3):537-548.
31. Yang YM, Seo SY, Kim TH, Kim SG. 2012. Decrease of micro- RNA-122 causes hepatic insulin resistance by inducing protein tyrosine phosphatase 1B, which is reversed by licorice flavonoid. Hepatology 56(6):2209-2220.
32. Ye J, McGuinness OP. 2013. Inflammation during obesity is not all bad: evidence from animal and human studies. Am J Physiol Endocrinol Metab 304(5):E466-E477.
33. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. 2000. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148(2):209-214.
34. Zhu L, Chen L, Shi CM, Xu GF, Xu LL, Zhu LL, Guo XR, Ni Y, Cui Y, Ji C. 2013. MiR-335, an adipogenesis-related Micro- RNA, is involved in adipose tissue inflammation. Cell Biochem Biophys [Epub ahead of print]; DOI: 10.1007/s12013-013-9708-3.